Skip to content Skip to sidebar Skip to footer

Newsletter

Technology

Cyclopharm (ASX:CYC): FDA approved for 2 years now, but a lawsuit from 4DX is the latest headache and cause for investor scepticism

Cyclopharm (ASX:CYC) is a rare species - an ASX stock that is approved in the US market. However, its share price has gone in the opposite direction. Cyclopharm has not had as fast an uplift as other companies have had and still makes most of its sales from other jurisdictions. A lawsuit from 4D Medical…

ByNick SundichOctober 8, 2025

Activist investors: Here’s what you need to know about them and 4 famous Australian activists to watch out for

Hear the term 'Activist investors' and you might think of GetUp, the progressive activist group that forced Woolworths to hold an EGM in 2014 in an attempt to limit the maximum bets on poker machines to $1. Or perhaps even of ESG-focused fundies like Australian Ethical (ASX:AEF). The reality is a lot more complicated and…

ByNick SundichOctober 8, 2025

Acusensus (ASX: ACE) Surges 18% on Major USD 22 Million U.S. Contract Win

The AI-Driven Road Safety Company Winning Government Contracts Worldwide Acusensus (ASX: ACE) grabbed investors’ attention today after its share price surged 18 percent on news of a major contract win in the United States. The company secured a deal worth an estimated USD 22 million to deliver automated work zone speed control systems across Connecticut, marking…

ByCharlie YouldenOctober 7, 2025

Weebit Nano’s 185% Rally, Onsemi Breakthrough Brings ReRAM Closer to Reality

Weebit Nano’s onsemi Milestone Strengthens Commercial Outlook After 185% Share Price Surge over the past 6 months Weebit Nano (ASX:WBT) has achieved a significant milestone in its journey toward commercialising its next-generation memory technology, Resistive Random Access Memory (ReRAM). The company has successfully completed the “tape-out” phase — the point where chip designs are finalised…

ByCharlie YouldenOctober 7, 2025

Nuix (ASX:NXL) has fallen 50% in 12 months! But shares may have taken a turn for the better in recent weeks

After closing 2024 with a share price that had more than tripled in 12 months, Nuix (ASX:NXL) has halved so far in 2025...but things might have taken a turn for the better recently, and shares are up 50% in the past 7 weeks. This company has been one of the most controversial companies on the ASX…

ByNick SundichOctober 7, 2025

Fermi Surges 55% in Market Debut After USD 682m IPO

Fermi’s Bold Entry: 55% IPO Rally for a Zero-Revenue Energy AI REIT Fermi (Nasdaq: FRMI) made one of the most dramatic market debuts in recent memory, climbing 55% from its USD 21 IPO price on its first day of trading. Yet this is far from a typical growth stock. Fermi is an early-stage company attempting…

ByCharlie YouldenOctober 2, 2025

Race Oncology Jumps 23% as Researchers Uncover Key Mechanism Behind Lead Cancer Drug

Race Oncology Soars 23% on Breakthrough Discovery Targeting MYC Race Oncology (ASX: RAC) opened strongly, rising 23 percent after releasing new insights into how its lead cancer drug, bisantrene (RC220 Bisantrene, RCDS1), actually works inside the body. The company’s researchers found that the drug attaches to and stabilises DNA and RNA structures known as…

ByCharlie YouldenOctober 2, 2025

Metallium (ASX: MTM) Surges 23% on Glencore Partnership: Full Investor Breakdown

Glencore Deal Sends Metallium (ASX: MTM) Shares Soaring 23% Metallium (ASX: MTM) has quickly become one of the most talked-about names on the ASX, with recent momentum driven by news that could reshape its path forward. The latest catalyst was a memorandum of understanding with a subsidiary of Glencore plc, one of the world’s largest…

ByCharlie YouldenOctober 2, 2025

DroneShield Surges 40% After Hitting 4,000 Units Sold and Securing AUD 7.9m in New Orders

Droneshield (ASX: DRO) has been one of the standout movers on the ASX in recent months, with the stock surging another 40 percent this week. For investors watching the defence technology space, this momentum reflects investor optimism on the back of the latest driver being a series of Department of Defence contracts that helped the…

ByCharlie YouldenOctober 1, 2025

The S&P/ASX All Technology Index: Here’s what investors need to know, and the 5 top stocks in it!

In the last 12 months, the S&P/ASX All Technology Index celebrated 6 years since inception and has netted a return of 27% vs the ASX 200's 7% gain as of September 24, 2025. We thought it was about time to write about this indice. Specifically how has it performed over time, the role it plays…

ByNick SundichSeptember 26, 2025

the Kick-ass Multipurpose WordPress Theme

Technology

Cyclopharm (ASX:CYC): FDA approved for 2 years now, but a lawsuit from 4DX is the latest headache and cause for investor scepticism

Activist investors: Here’s what you need to know about them and 4 famous Australian activists to watch out for

Acusensus (ASX: ACE) Surges 18% on Major USD 22 Million U.S. Contract Win

Weebit Nano’s 185% Rally, Onsemi Breakthrough Brings ReRAM Closer to Reality

Nuix (ASX:NXL) has fallen 50% in 12 months! But shares may have taken a turn for the better in recent weeks

Fermi Surges 55% in Market Debut After USD 682m IPO

Race Oncology Jumps 23% as Researchers Uncover Key Mechanism Behind Lead Cancer Drug

Metallium (ASX: MTM) Surges 23% on Glencore Partnership: Full Investor Breakdown

DroneShield Surges 40% After Hitting 4,000 Units Sold and Securing AUD 7.9m in New Orders

The S&P/ASX All Technology Index: Here’s what investors need to know, and the 5 top stocks in it!

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

Technology

Add Your Heading Text Here